^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
BIOMARKER:

FGFR3-TACC3 fusion

i
Other names: FGFR3, ACH, CD333, CEK2, JTK4, Fibroblast growth factor receptor 3, TACC3, Transforming acidic coiled-coil containing protein 3, ERIC-1
Entrez ID:
FGFR3-TACC3 fusion
Glioblastoma
anlotinib
Sensitive
:
C3
FGFR3-TACC3 fusion
Gallbladder Cancer
Debio 1347
Sensitive
:
C3
FGFR3-TACC3 fusion
Urothelial Cancer
infigratinib
Sensitive
:
C3
FGFR3-TACC3 fusion
Urothelial Cancer
Debio 1347
Sensitive
:
C3
FGFR3-TACC3 fusion
Glioblastoma
erdafitinib
Sensitive
:
C3
FGFR3-TACC3 fusion
Non Small Cell Lung Cancer
infigratinib
Sensitive
:
C3
FGFR3-TACC3 fusion
Non Small Cell Lung Cancer
ponatinib
Sensitive
:
C3
FGFR3-TACC3 fusion
Gastric Cancer
futibatinib
Sensitive
:
C3
FGFR3-TACC3 fusion
Glioma
anlotinib
Sensitive
:
C4
FGFR3-TACC3 fusion
Adrenal Cortex Carcinoma
erdafitinib
Sensitive
:
C4
FGFR3-TACC3 fusion
Astrocytoma
ABSK091
Sensitive
:
C4
FGFR3-TACC3 fusion
Endometrial Cancer
erdafitinib
Sensitive
:
C4
FGFR3-TACC3 fusion
Bladder Cancer
erdafitinib
Sensitive
:
C4
FGFR3-TACC3 fusion
Urothelial Cancer
atezolizumab
Sensitive
:
C4
FGFR3-TACC3 fusion
Bladder Cancer
futibatinib
Sensitive
:
D
FGFR3-TACC3 fusion
Urothelial Cancer
erdafitinib
Sensitive
:
D
FGFR3-TACC3 fusion
Bladder Cancer
MPT0L145
Sensitive
:
D
FGFR3-TACC3 fusion
Cholangiocarcinoma
infigratinib
Sensitive
:
D
FGFR3-TACC3 fusion
Urothelial Cancer
dasatinib + infigratinib
Sensitive
:
D